resveratrol has been researched along with Blunt Injuries in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ilhan, YS; Yilmaz, AF; Yilmaz, N | 1 |
| Chen, J; Fei, DD; Hu, CH; Huang, WT; Jin, Y; Liu, N; Lu, YB; Lv, YJ; Pang, DL; Sui, BD; Xuan, K; Zhao, P; Zheng, CX; Zhou, CH | 1 |
| Akdemir, HU; Torun, AC; Tutuncu, S; Ustun, B | 1 |
| Çağlar Torun, A; Tütüncü, Ş | 1 |
4 other study(ies) available for resveratrol and Blunt Injuries
| Article | Year |
|---|---|
Resveratrol ameliorates hepatic injury and modulates hepatic biomarkers of regeneration, apoptosis and survival in a rat model of blunt hepatic trauma.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Biomarkers; Liver; Rats; Rats, Wistar; Regeneration; Resveratrol; Wounds, Nonpenetrating | 2020 |
Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application.
Topics: Acetyl-CoA Carboxylase; Administration, Cutaneous; Aging; AMP-Activated Protein Kinases; Animals; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Enzyme Activation; Female; Gene Expression Regulation; Metformin; Mice; Neovascularization, Physiologic; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Sprague-Dawley; Resveratrol; Ribosomal Protein S6 Kinases; Sirolimus; Skin; Skin Aging; Stilbenes; Tumor Suppressor Protein p53; Wound Healing; Wounds, Nonpenetrating | 2017 |
A Study of the Therapeutic Effects of Resveratrol on Blunt Chest Trauma-Induced Acute Lung Injury in Rats and the Potential Role of Endocan as a Biomarker of Inflammation.
Topics: Acute Lung Injury; Animals; Antioxidants; Biomarkers; Inflammation; Proteoglycans; Rats; Resveratrol; Stilbenes; Thoracic Injuries; Wounds, Nonpenetrating | 2017 |
Assessing the therapeutic effect of resveratrol in heart failure following blunt chest trauma and the potential role of endocan as a biomarker of inflammation using rats.
Topics: Animals; Antioxidants; Biomarkers; Heart Failure; Inflammation; Male; Nitric Oxide Synthase Type II; Proteoglycans; Random Allocation; Rats; Resveratrol; Thoracic Injuries; Tumor Necrosis Factor-alpha; Wounds, Nonpenetrating | 2019 |